Levonest NDC 50090-2505

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-2505Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-2505Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-2505-0	50090250500	1 KIT in 1 KIT (50090-2505-0)Marketed from Oct 13, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levonest
Generic name (nonproprietary): levonorgestrel and ethinyl estradiol
Dosage form: Kit
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090719
Marketing start: Dec 29, 2010
Listing expires: Dec 31, 2026
Identifiers: Product ID 50090-2505_9d2a8723-9b52-4445-b3bc-82282791e1f4SPL ID 9d2a8723-9b52-4445-b3bc-82282791e1f4SPL set ID dfda3568-b626-4194-b0af-df5d2ea69e3fRxCUI 310230, 348804, 348805, 748797, 748832, 1095227

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N450090250500 followed by a unit qualifier and the quantity

Package 50090-2505-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 3, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table II lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization and the IUD, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. TABLE II: PERCENTAGE OF WOMEN EXPERIENCING AN UNINTENDED PREGNANCY DURING THE FIRST YEAR OF USE OF A CONTRACEPTIVE METHOD Method Perfect Use Typical Use Levono…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090719

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090719
Product	Strength	Form · route	Labeler	Product NDC
Levonestlevonorgestrel and ethinyl estradiol	—	Kit	Northstar Rx LLC	16714-340